Atara Biotherapeutics, Inc. (ATRA)
4.16
-0.08
(-1.89%)
USD |
NASDAQ |
Feb 20, 13:53
Atara Biotherapeutics Profit Margin (Quarterly) : -124.6% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Pfizer Inc. | -9.34% |
| Vertex Pharmaceuticals, Inc. | 36.91% |
| AbbVie, Inc. | 10.92% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 30.72% |
| Return on Invested Capital | 212.3% |
| Gross Profit Margin (Quarterly) | 96.67% |
| Operating Margin (Quarterly) | -102.7% |
| Return on Net Operating Assets | 64.68% |